- Sputnik International, 1920
World
Get the latest news from around the world, live coverage, off-beat stories, features and analysis.

Russia's EpiVacCorona Vaccine Develops Antibodies in 94% of Senior Citizens, Developer Says

© Sputnik / Grigory Sysoev / Go to the mediabankA view shows packages of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia
A view shows packages of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia - Sputnik International, 1920, 07.04.2021
Subscribe
International
India
MOSCOW (Sputnik) - As many as 94 percent of senior citizens develop antibodies against the coronavirus after being inoculated with Russia's EpiVacCorona vaccine, the head of the Yekaterinburg department of Russia's Vector research institute that developed the vaccine said on Wednesday.

"We know for sure that the vaccine can be used by all people aged over 18, we will now go down [proceed to vaccination of younger citizens]. We understand that vaccine injection results in the development of effective antibodies in 94 percent of cases," Alexander Semyonov told the Soloviev Live YouTube show.

Packaging of injectable preparations for the syringe-dose of the EpiVacCorona vaccine for the prevention of COVID-19, produced at the Vector-BiAlgam enterprise in Novosibirsk. - Sputnik International, 1920, 31.03.2021
Venezuela Receives Batch of Russia's EpiVacCorona Vaccine for Study, Minister Says
Russian consumer rights watchdog Rospotrebnadzor specified later that Semyonov was talking about antibodies in people aged 60+.

EpiVacCorona vaccine was authorised for seniors aged 60 and over in March.

The vaccine is a peptide-based drug that relies on a synthetic platform. Artificially-synthesised short fragments of viral proteins - peptides, which are contained in the vaccine, help the immune system learn how to recognise and then neutralise the virus.

Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала